Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines

Lung Cancer

Volumn 54, Issue 2, 2006, Pages 149-153

  Kuhn, Hartmut ^a   Konrad, Jana ^a   Holtz, Silke ^a   Salameh, Aida ^a   Gessner, Christian ^a   Hammerschmidt, Stefan ^a   Wirtz, Hubert ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

bFGF; p42 44 MAP kinase; Tumor angiogenesis; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS;

ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PATHOLOGIC; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; SIGNAL TRANSDUCTION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33751082152     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.07.016     Document Type: Article

References (25)

1. Hoang T., Traynor A.M., and Schiller J.H. Novel therapies for lung cancer. Surg Oncol 11 (2002) 229-241
2. Ferreira C.G., Huisman C., and Giaccone G. Novel approaches to the treatment of non-small cell lung cancer. Crit Rev Oncol Hematol 41 (2002) 57-77
3. Takanami I., Tanaka F., Hashizume T., Kikuchi K., Yamamoto Y., Yamamoto T., et al. The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur J Cancer 32A (1996) 1504-1509
4. Ueno K., Inoue Y., Kawaguchi T., Hosoe S., and Kawahara M. Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis. Lung Cancer 31 (2001) 213-219
5. Guddo F., Fontanini G., Reina C., Vignola A.M., Angeletti A., and Bonsignore G. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression. Hum Pathol 30 (1999) 788-794
6. Kuhn H., Köpff C., Konrad J., Riedel A., Gessner C., and Wirtz H. Influence of basic fibroblast growth factor in the proliferation of non-small cell lung cancer cell lines. Lung Cancer 44 167 (2004) 174
7. Levin E.G., Sikora L., Ding L., Rao S.P., and Sriramarao P. Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2. Am J Pathol 164 (2004) 1183-1190
8. Ozen M., Medrano E.E., and Ittmann M. Inhibition of proliferation and survival of melanoma cells by adenoviral-mediated expression of dominant negative fibroblast growth factor receptor. Melanoma Res 14 (2004) 13-21
9. Amoroso A., Del Porto F., Di Monaco C., Manfredini P., and Afeltra A. Vascular endothelial growth factor: a key mediator of neoangiogenesis A review. Eur Rev Med Pharmacol Sci 1 (1997) 17-25
10. Tsai J.C., Goldman C.K., and Gillespie G.Y. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82 (1995) 864-873
11. Winer J., Jung C.K., Shackel I., and Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270 (1999) 41-49
12. Pages G., Milanini J., Richard D.E., Berra E., Gothie E., Vinals F., et al. Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann NY Acad Sci 902 (2000) 187-200
13. Iwasaki A., Kuwahara M., Yoshinaga Y., and Shirakusa T. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Eur J Cardiothorac Surg 25 (2004) 443-448
14. Rabie A.B., and Lu M. Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor during healing of allogeneic bone graft. Arch Oral Biol 49 (2004) 1025-1033
15. Giavazzi R., Sennino B., Coltrini D., Garofalo A., Dossi R., Ronca R., et al. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. Am J Pathol 162 (2003) 1913-1926
16. Polytarchou C., Gligoris T., Kardamakis D., Kotsaki E., and Papadimitriou E. X-rays affect the expression of genes involved in angiogenesis. Anticancer Res 24 (2004) 2941-2945
17. Fersis N., Smyczek-Gargya B., Armeanu S., Gagulic E., Pantic L., Relakis K., et al. Changes in vascular endothelial growth factor (VEGF) after chemoendocrine therapy in breast cancer. Eur J Gynaecol Oncol 25 (2004) 45-50
18. Kuhn H., Bräunlich J., Hammerschmidt S., and Wirtz H. Candidate genes upregulated in density dependent growth inhibition of lung cancer cells. Int J Oncol 25 (2004) 1481-1487
19. Berra E., Milanini J., Richard D.E., Le Gall M., Vinals F., Gothie E., et al. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60 (2000) 1171-1178
20. Milanini J., Vinals F., and Pouyssegur J. Pages G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273 (1998) 18165-18172
21. Mori K., Tani M., Kamata K., Kawamura H., Urata Y., Goto S., et al. Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells. Free Radic Res 33 (2000) 157-166
22. Shi Y.H., Wang Y.X., Bingle L., Gong L.H., Heng W.J., Li Y., et al. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J Pathol 205 (2005) 530-536
23. Hortala M., Estival A., Pradayrol L., Susini C., and Clemente F. Identification of c-Jun as a critical mediator for the intracrine 24 kDa FGF-2 isoform-induced cell proliferation. Int J Cancer 114 (2005) 863-869
24. Kohno M., and Pouyssegur J. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog Cell Cycle Res 5 (2003) 219-224
25. Solban N., Pal S.K., Alok S.K., Sung C.K., and Hasan T. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer. Cancer Res 66 (2006) 5633-5640